Cargando…
Drug Repositioning as a Therapeutic Strategy against Streptococcus pneumoniae: Cell Membrane as Potential Target
A collection of repurposing drugs (Prestwick Chemical Library) containing 1200 compounds was screened to investigate the drugs’ antimicrobial effects against planktonic cultures of the respiratory pathogen Streptococcus pneumoniae. After four discrimination rounds, a set of seven compounds was final...
Autores principales: | Ortiz-Miravalles, Laura, Sánchez-Angulo, Manuel, Sanz, Jesús M., Maestro, Beatriz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058218/ https://www.ncbi.nlm.nih.gov/pubmed/36982905 http://dx.doi.org/10.3390/ijms24065831 |
Ejemplares similares
-
Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New Antimicrobials
por: Maestro, Beatriz, et al.
Publicado: (2016) -
Choline-Functionalized Supramolecular Copolymers:
Toward Antimicrobial Activity against Streptococcus
pneumoniae
por: Vleugels, Marle E. J., et al.
Publicado: (2021) -
Drug Repositioning for Gynecologic Tumors: A New Therapeutic Strategy for Cancer
por: Banno, Kouji, et al.
Publicado: (2015) -
Drug repositioning as a therapeutic strategy for neurodegenerations associated with OPA1 mutations
por: Aleo, Serena J, et al.
Publicado: (2020) -
Recent computational drug repositioning strategies against SARS-CoV-2
por: Lu, Lu, et al.
Publicado: (2022)